Cristina Mendez

Alcobendas, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain.

Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain.

Journal: Infectious diseases and therapy
Published: February 07, 2024

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016-2020: The CAPA Study.

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016-2020: The CAPA Study.

Journal: Microorganisms
Published: October 17, 2023

Whole exome sequencing identifies new susceptibility candidates underlying community-acquired pneumonia.

Whole exome sequencing identifies new susceptibility candidates underlying community-acquired pneumonia.

Journal: Genes & diseases
Published: June 30, 2023

Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain.

Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain.

Journal: Vaccine
Published: May 19, 2023

Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review.

Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review.

Journal: Microorganisms
Published: March 10, 2023

Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019.

Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019.

Journal: Human vaccines & immunotherapeutics
Published: June 15, 2022

All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain.

All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain.

Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 24, 2021

Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Journal: Human vaccines & immunotherapeutics
Published: June 09, 2021

CAPPRIC Study-Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings.

CAPPRIC Study-Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings.

Journal: Microorganisms
Published: December 21, 2020

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018.

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 26, 2020

Comment on "Vila-Córcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."

Comment on "Vila-Córcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."

Journal: Vaccine
Published: January 10, 2020

Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.

Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.

Journal: Vaccine
Published: October 11, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026